Electronics manufacturing services provider Benchmark (NYSE: BHE) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 3.5% year on year to $680.7 million. The company expects next quarter’s revenue to be around $695 million, close to analysts’ estimates. Its non-GAAP profit of $0.62 per share was 8.1% above analysts’ consensus estimates.

Is now the time to buy BHE? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Benchmark’s third quarter performance was met with a positive market response, supported by broad-based sector contributions and strong execution on new program wins. Management highlighted double-digit growth in both medical and aerospace & defense (A&D), while industrial and advanced computing & communications (AC&C) also posted sequential gains. CEO Jeffrey Benck noted, “I was particularly encouraged by the broadening of sectors that contributed to our revenue growth,” and pointed to a multiyear record in cash cycle efficiency, reflecting disciplined working capital management. Supply chain normalization in the medical segment and new product ramps provided additional lift, offsetting some softness in semi-cap equipment due to external trade restrictions and cyclical headwinds.

Looking ahead, Benchmark’s guidance is underpinned by continued strength in its medical, A&D, and industrial sectors, alongside emerging opportunities in AI-related advanced computing. President David Moezidis referenced new engineering wins in medtech and emphasized that “AI wins are starting to ramp in Q4 and into 2026, coupled with HPC builds over the coming quarters.” While management acknowledged ongoing challenges in semi-cap from tariffs and demand timing, they expressed confidence in sequential and year-over-year growth, supported by a growing pipeline and strategic investments in capacity, particularly in Penang, Malaysia. Management also highlighted their expectation for incremental growth in 2026 to drive operating leverage and earnings expansion.

Key Insights from Management’s Remarks

Management attributed quarterly performance to diversified sector growth, disciplined working capital management, and new program bookings, while highlighting sector-specific challenges and opportunities.

• Medical segment recovery: The medical sector experienced both sequential and year-over-year growth as customer inventory levels normalized and new product ramps gained momentum. Management credited engineering wins in medtech as a key entry point for future manufacturing business.
• Aerospace & defense momentum: Double-digit revenue growth in A&D was driven by strong defense demand, particularly in Europe and the Americas, as well as accelerating bookings in the satellite and space subsectors. President David Moezidis noted recent substantial manufacturing wins in space communications.
• Industrial sector stability: The industrial business returned to year-over-year growth, aided by new wins in transportation and surveillance. Management sees industrial as a significant future growth engine, citing ongoing expansion of the customer base and design contracts.
• AC&C AI-driven outlook: AC&C saw improved visibility into growth, with management pointing to AI and high-performance computing (HPC) wins that are expected to ramp into late 2025 and 2026. CEO Jeffrey Benck described Benchmark’s focus on sovereign and enterprise AI opportunities over hyperscale cloud providers.
• Semi-cap headwinds and investments: Semi-cap revenue was flat, with management citing near-term demand challenges from China restrictions and tariffs. However, continued investments in precision machining—especially in Malaysia—position Benchmark to capture share as the sector recovers, with customers signaling optimism for a second-half 2026 upturn.

Drivers of Future Performance

Management expects future performance to be shaped by sector diversification, new technology adoption, and ongoing investments in capacity and automation.

• AI and HPC program ramps: Benchmark anticipates that recently secured AI and high-performance computing contracts in AC&C will drive incremental revenue growth, especially as buildouts for government and enterprise customers accelerate throughout 2026. Management highlighted that their water-cooled infrastructure supports these projects and enables participation in sovereign and enterprise AI opportunities.
• Medical and industrial sector growth: The company expects medical and industrial segments to deliver continued sequential and year-over-year growth, supported by normalized channel inventories and new customer wins. Management views medtech engineering contracts and transportation-related programs as sources of ongoing upside.
• Cyclical semi-cap recovery: While near-term demand in semi-cap remains mixed due to external trade factors, management is cautiously optimistic that customer activity will pick up in the second half of 2026, citing positive signals from industry events and customer engagements. Investments in domestic and Malaysian capacity are designed to capture this expected rebound.

Catalysts in Upcoming Quarters

Looking forward, StockStory analysts will focus on (1) the pace of AI and HPC program ramp-ups in AC&C and whether early customer pilots convert to sustained production, (2) medical segment momentum as new engineering wins move into manufacturing, and (3) visibility into a semi-cap recovery, particularly the timing and magnitude of customer order growth. Additional signposts include progress on capacity expansion in Malaysia and any changes to defense or government spending trends.

Benchmark currently trades at $44.25, up from $43.01 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free for active Edge members).

Stocks That Trumped Tariffs

Fresh US-China trade tensions just tanked stocks—but strong bank earnings are fueling a sharp rebound. Don’t miss the bounce.

Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.